Premium
Intra‐prostatic vasculature studies: Can they predict the outcome of transurethral microwave thermotherapy for the management of bladder outflow obstruction?
Author(s) -
Floratos Diamandis L.,
Michiel Sedelaar J.P.,
Kortmann Barbara B.M.,
Aarnink Rene G.,
Wijkstra Hessel,
Debruyne Frans M.J.,
de la Rosette Jean J.M.C.H.
Publication year - 2001
Publication title -
the prostate
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.295
H-Index - 123
eISSN - 1097-0045
pISSN - 0270-4137
DOI - 10.1002/1097-0045(20010215)46:3<200::aid-pros1024>3.0.co;2-j
Subject(s) - medicine , urology , prostate , blood flow , perfusion , lower urinary tract symptoms , nuclear medicine , cancer
Background Blood perfusion regulates intraprostatic temperatures during transurethral microwave thermotherapy (TUMT). We evaluated baseline intraprostatic vasculature, as a predictor of efficacy of TUMT. Methods Twenty‐two patients, with lower urinary tract symptoms (LUTS) suggestive of bladder outflow obstruction, were treated with TUMT (Prostatron). At baseline, three‐dimensional contrast‐enhanced power‐flow‐Doppler prostate ultrasonography (3D‐CE‐PFD) was performed. Assuming that the percentage of perfused area (PPA) is a realistic measure of blood flow, it was used to quantify intraprostatic vasculature. Results The median (range) age, prostate size, and energy delivered were 66 years (48–80), 47 cm 3 (30–121), 110 kJ (29–136), respectively. The response was 77% (5 failures). The median (range) PPA was 2.76% (0.7–11.3). No difference in PPA among good and poor responders was detected nor was any correlation between PPA and baseline parameters. Conclusions The baseline intraprostatic vascularization, documented by CE‐PFD studies, has no predictive value for the efficacy of TUMT. It seems that “static” baseline blood flow does not reflect the “dynamic” thermoregulatory role of blood flow during treatment. Prostate 46:200–206, 2001. © 2001 Wiley‐Liss, Inc.